Lukianova N - Search Results

1

FEATURES OF COL1A1 EXPRESSION IN BREAST CANCER TISSUE OF YOUNG PATIENTS.

Chekhun V, Mushii O, Zadvornyi T, Borikun T, Martyniuk О, Kashuba E, Kryzhanivska A, Andriiv A, Diakiv I, Lukianova N. Chekhun V, et al. Among authors: lukianova n. Exp Oncol. 2023 Dec 28;45(3):351-363. doi: 10.15407/exp-oncology.2023.03.351. Exp Oncol. 2023. PMID: 38186020

2

[Visualization of iron nanoparticles accumulation and distribution features in sensitive and resistant to antitumor drugs human breast cancer cells after different time intervals of cultivation with liposomal ferromagnetic].

Nalieskina LA, Luk'ianova NIu, Kuns'ka LM, Demash DV, Chekhun VF. Nalieskina LA, et al. Tsitol Genet. 2011 Nov-Dec;45(6):61-6. Tsitol Genet. 2011. PMID: 22329164 Ukrainian.

3

Mast cells as a tumor microenvironment factor associated with the aggressiveness of prostate cancer.

Zadvornyi T, Lukianova N, Borikun T, Tymoshenko A, Mushii O, Voronina O, Vitruk I, Stakhovskyi E, Chekhun V. Zadvornyi T, et al. Among authors: lukianova n. Neoplasma. 2022 Dec;69(6):1490-1498. doi: 10.4149/neo_2022_221014N1020. Neoplasma. 2022. PMID: 36591806

4

EVALUATION OF DIAGNOSTIC ALGORITHM BASED ON COLLAGEN ORGANIZATION PARAMETERS FOR BREAST TUMORS.

Lukianova N, Zadvornyi T, Mushii О, Pyatchanina T, Chekhun V. Lukianova N, et al. Exp Oncol. 2022 Dec;44(4):281-286. doi: 10.32471/exp-oncology.2312-8852.vol-44-no-4.19137. Exp Oncol. 2022. PMID: 36811534

5

Does insulin make breast cancer cells resistant to doxorubicin toxicity?

Lykhova O, Zavelevich M, Philchenkov A, Vidasov N, Kozak T, Lozovska Y, Andrusyshyna I, Bishayee A, Borikun T, Lukianova N, Chekhun V. Lykhova O, et al. Among authors: lukianova n. Naunyn Schmiedebergs Arch Pharmacol. 2023 Nov;396(11):3111-3122. doi: 10.1007/s00210-023-02516-3. Epub 2023 May 25. Naunyn Schmiedebergs Arch Pharmacol. 2023. PMID: 37231169

6

PATTERN OF MMP2 AND MMP9 EXPRESSION DEPENDS ON BREAST CANCER PATIENTS' AGE.

Lukianova N, Mushii O, Borikun T, Zadvornyi T, Bazas V, Krotevych M, Sivak L, Lyalkin S, Martynyuk О, Hrybach S, Chekhun V. Lukianova N, et al. Exp Oncol. 2023 Jun 26;45(1):17-27. doi: 10.15407/exp-oncology.2023.01.017. Exp Oncol. 2023. PMID: 37417285

7

FEATURES OF BREAST CANCER IN PATIENTS OF YOUNG AGE: SEARCH FOR DIAGNOSIS OPTIMIZATION AND PERSONALIZED TREATMENT.

Chekhun V, Martynyuk О, Lukianova Y, Mushii O, Zadvornyi T, Lukianova N. Chekhun V, et al. Among authors: lukianova n. Exp Oncol. 2023 Oct 11;45(2):139-150. doi: 10.15407/exp-oncology.2023.02.139. Exp Oncol. 2023. PMID: 37824778 Review.

8

Osteonectin (SPARC) prognostic value in prostate cancer.

Chekhun V, Borikun T, Zadvornyi T, Mushii O, Stakhovsky E, Vitruk Y, Lukianova N. Chekhun V, et al. Among authors: lukianova n. Pathol Res Pract. 2024 Feb;254:155053. doi: 10.1016/j.prp.2023.155053. Epub 2023 Dec 27. Pathol Res Pract. 2024. PMID: 38199134

9

EXPRESSION PROFILE OF miR-145, -182, -21, -27a, -29b, and -34a IN BREAST CANCER PATIENTS OF YOUNG AGE.

Chekhun V, Borikun T, Mushii O, Zadvornyi T, Martyniuk О, Kashuba E, Bazas V, Hrybach S, Krotevych M, Lyalkin S, Lukianova N. Chekhun V, et al. Among authors: lukianova n. Exp Oncol. 2024 Feb 3;45(4):421-431. doi: 10.15407/exp-oncology.2023.04.421. Exp Oncol. 2024. PMID: 38328848

10

EXPRESSION OF SPP1 AND SPARC GENES IN TUMOR TISSUE OF PATIENTS WITH BREAST CANCER.

Chekhun V, Pavlova A, Zadvornyi T, Borikun T, Naleskina L, Mushii O, Bazas V, Lukianova N. Chekhun V, et al. Among authors: lukianova n. Exp Oncol. 2024 May 31;46(1):13-21. doi: 10.15407/exp-oncology.2024.01.013. Exp Oncol. 2024. PMID: 38852057

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

82 results

Search Page

Filters